Next-generation targeted panel sequencing by MSK-IMPACT of the tumor specimen detected a KIT exon 11 mutation (D579del) and alterations in NF1, TP53, RB1, and PTCH1, with loss of PTEN and RAC2 by copy number (Figure 3). The gene discussed is KIT; the disease is neoplasm.